Moreover, the risk of liver pathology is increased in cohorts of patients with severe COVID-19 and an increase in ALT/AST/GGT is an independent predictor of adverse effects during coronavirus disease and concomitant hospital admission [64,66]. The gene discussed is GPT; the disease is COVID-19.